ENLV

Enlivex Ltd. Ordinary Shares

1.10

USD

ENLV Earnings Reports

Positive Surprise Ratio

ENLV beat 17 of 29 last estimates.

59%

Next Report

Next Week

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.03

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-86.96%

Enlivex Ltd. Ordinary Shares earnings per share and revenue

On --, ENLV reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.03 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Context Therapeutics Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.14

Surprise

-29.39%

Avalo Therapeutics, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$1.49

Actual

-$1.12

Surprise

+24.33%

Journey Medical Corporation Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.04

Surprise

+31.86%

Surrozen, Inc. Common

Report Date

Mar 30, 2026 For Q4 25

Estimate

-$1.21

Actual

Surprise

Achieve Life Sciences, Inc.

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.28

Surprise

-1.12%

Vivani Medical, Inc. Common Stock (DE)

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.09

Surprise

Pyxis Oncology, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.34

Actual

-$0.28

Surprise

+15.55%

Acrivon Therapeutics, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.34%

Fractyl Health, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

$0.15

Surprise

+181.70%

NRX Pharmaceuticals, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

$0.00

Actual

-$0.01

Surprise

-361.54%

FAQ

What were Enlivex Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Enlivex Ltd. Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Enlivex Ltd. Ordinary Shares's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Enlivex Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Enlivex Ltd. Ordinary Shares's next earnings report?

Based on 3 analysts, Enlivex Ltd. Ordinary Shares is expected to report EPS of -$0.03 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.